These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 10398124

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation.
    Bartkova J, Lukas J, Strauss M, Bartek J.
    Oncogene; 1998 Aug 27; 17(8):1027-37. PubMed ID: 9747882
    [Abstract] [Full Text] [Related]

  • 3. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
    Bartkova J, Lukas J, Müller H, Strauss M, Gusterson B, Bartek J.
    Cancer Res; 1995 Feb 15; 55(4):949-56. PubMed ID: 7850812
    [Abstract] [Full Text] [Related]

  • 4. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis.
    Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT, Elledge SJ, Weinberg RA.
    Nature; 1996 Dec 05; 384(6608):470-4. PubMed ID: 8945475
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cyclin D3 expression in normal, reactive and neoplastic tissues.
    Doglioni C, Chiarelli C, Macrí E, Dei Tos AP, Meggiolaro E, Dalla Palma P, Barbareschi M.
    J Pathol; 1998 Jun 05; 185(2):159-66. PubMed ID: 9713342
    [Abstract] [Full Text] [Related]

  • 7. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
    Ma Y, Feng Q, Sekula D, Diehl JA, Freemantle SJ, Dmitrovsky E.
    Cancer Res; 2005 Jul 15; 65(14):6476-83. PubMed ID: 16024653
    [Abstract] [Full Text] [Related]

  • 8. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E, Peschos D, Goussia A, Mittari E, Charalabopoulos K, Michael M, Salmas M, Vougiouklakis T, Assimakopoulos D, Agnantis NJ.
    J Exp Clin Cancer Res; 2004 Jun 15; 23(2):277-83. PubMed ID: 15354413
    [Abstract] [Full Text] [Related]

  • 9. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast.
    Wong SC, Chan JK, Lee KC, Hsiao WL.
    J Pathol; 2001 May 15; 194(1):35-42. PubMed ID: 11329139
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. G1-phase regulators, cyclin D1, cyclin D2, and cyclin D3: up-regulation at gastrulation and dynamic expression during neurulation.
    Wianny F, Real FX, Mummery CL, Van Rooijen M, Lahti J, Samarut J, Savatier P.
    Dev Dyn; 1998 May 15; 212(1):49-62. PubMed ID: 9603423
    [Abstract] [Full Text] [Related]

  • 16. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E.
    Int J Clin Pract; 2008 Nov 15; 62(11):1736-43. PubMed ID: 19143860
    [Abstract] [Full Text] [Related]

  • 17. Crucial roles of D-type cyclins in the early stage of adipocyte differentiation.
    Hishida T, Naito K, Osada S, Nishizuka M, Imagawa M.
    Biochem Biophys Res Commun; 2008 May 30; 370(2):289-94. PubMed ID: 18374658
    [Abstract] [Full Text] [Related]

  • 18. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
    Pokrovskaja K, Ehlin-Henriksson B, Bartkova J, Bartek J, Scuderi R, Szekely L, Wiman KG, Klein G.
    Cell Growth Differ; 1996 Dec 30; 7(12):1723-32. PubMed ID: 8959341
    [Abstract] [Full Text] [Related]

  • 19. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK.
    Br J Cancer; 2001 Jan 30; 84(2):270-5. PubMed ID: 11161387
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.